drugset / Trial / NCT02770209

Autologous Cell-derived Tissue Engineered Cartilage for Repairing Articular Cartilage Lesions

NCT02770209

Unknown 100 enrolled Chinese PLA General Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

This study is aimed at evaluating the feasibility and effectiveness of a completely natural tissue engineered cartilage, composed of a self-made tissue engineered oriented scaffold and autologous chondrocytes, for repairing articular cartilage damage following injury. And it is also aimed at investigating the safety of tissue engineered cartilage transplantation.

Timeline

Start
2012-02
Primary completion
2013-08
Completion
2016-06

Drugs

EvaluationDrugModalityDoseRoute
Subject autologous chondrocytes Cell therapy